<DOC>
	<DOCNO>NCT00705159</DOCNO>
	<brief_summary>The objective study evaluate safety effectiveness Zylet comparison Lotemax , Tobramycin vehicle Zylet treatment blepharoconjunctivitis pediatric subject .</brief_summary>
	<brief_title>Safety Efficacy Zylet v Lotemax , Tobramycin Vehicle Pediatric Blepharoconjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Tobramycin</mesh_term>
	<mesh_term>Loteprednol Etabonate</mesh_term>
	<criteria>child 06 year age . clinical diagnosis blepharoconjunctivitis Parent/guardian must understand , willing able comply treatment followup procedure . Parent/guardian must understand , willing able provide inform consent Health Insurance Portability Accountability Act ( HIPAA ) authorization . Known hypersensitivity corticosteroid , aminoglycosides , component study medication . Subjects history ocular surgery , include laser procedure , within past 6 month . Subjects monocular . Subjects history severe/serious ocular pathology medical condition could result subject 's inability complete study . Subjects participate ophthalmic drug device research study within 30 day prior entry study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Blepharokeratoconjunctivitis</keyword>
</DOC>